<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02833545</url>
  </required_header>
  <id_info>
    <org_study_id>751-15-RMC</org_study_id>
    <nct_id>NCT02833545</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis</brief_title>
  <official_title>Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, Interventional, Non-Randomized, Open Label, Single Group Assignment, Single
      Center.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Actual">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>A sequential series of patients receiving steroid injections was compared to a sequential series of patients receiving ozone injections</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>the outcome assessor was not aware of the therapy administered</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in VAS Pain intensity</measure>
    <time_frame>6 months</time_frame>
    <description>The outcome measure will be measured according to patient response to the question: during the last week what was your average pain intensity. The response will be measured in millimeters as marked on a 10 cm long line. No pain equals 0 mm and maximal possible pain equals 100mm</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Osteoarthritis Knee</condition>
  <arm_group>
    <arm_group_label>OZONE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection of ozone gas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injeciton of steroids intra articularly</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ozone gas</intervention_name>
    <description>Injection of ozone gas intra articularly</description>
    <arm_group_label>OZONE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid injection</intervention_name>
    <description>Injection of steroids (diprospan) intra articularly</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  55 to 79 years of age

          -  Symptomatic Knee osteoarthritis

          -  VAS pain intensity is at least 40 mm on a 100 mm scale

          -  Must be physically and mentally willing and able to comply with post-operative
             rehabilitation and routinely schedule clinical and radiographic visits.

        Exclusion Criteria:

          -  Any known tumor of the ipsilateral knee.

          -  Any known infection of the treated knee.

          -  Osteoarthritis of the operated knee Kelgren Lawrence &lt; grade 2.

          -  Chemotherapy treatment in the past 12 months.

          -  Patients who are sensitive to ozone.

          -  Pregnant women, or breastfeeding women.

          -  Evidence of any significant systemic disease (such as but not limited to HIV
             infection, hepatitis infection or HTLV infection), known coagulopathies, that might
             compromise the Subject's welfare.

          -  Substance abuse or alcohol abuse.

          -  Participation in other clinical trials in parallel to this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 19, 2016</study_first_submitted>
  <study_first_submitted_qc>July 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2016</study_first_posted>
  <last_update_submitted>August 30, 2018</last_update_submitted>
  <last_update_submitted_qc>August 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>DROR ROBINSON</investigator_full_name>
    <investigator_title>Head Orthopedic Research Unit</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

